Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ultomiris
Ultomiris
AstraZeneca’s rare disease unit overcomes FDA snub to expand Ultomiris in NMOSD
Fierce Pharma
Mon, 03/25/24 - 10:31 pm
AstraZeneca
Soliris
NMOSD
Ultomiris
FDA blocks new use for AstraZeneca's Ultomiris
Pharmaphorum
Wed, 09/6/23 - 10:10 am
AstraZeneca
Ultomiris
Soliris
FDA
NMOSD
EHA 2023 – Astrazeneca keeps up its complement defense
EP Vantage
Fri, 06/9/23 - 10:01 am
EHA
AstraZeneca
Alexion
Soliris
Ultomiris
Novartis
iptacopan
PNH
AstraZeneca's Alexion hopes to extend dominance in PNH as Big Pharma competitors close in
Fierce Biotech
Fri, 12/16/22 - 10:47 am
AstraZeneca
Alexion
PNH
Ultomiris
Soliris
Roche
Apellis
Novartis
Novartis, eyeing $3B market, beats AstraZeneca blood disorder blockbusters in phase 3
Fierce Biotech
Mon, 10/24/22 - 11:17 pm
Novartis
iptacopan
clinical trials
Soliris
AstraZeneca
Ultomiris
AstraZeneca wins two recommendations, one priority review
Morningstar
Mon, 07/25/22 - 10:54 am
AstraZeneca
Europe
Daiichi Sankyo
Enhertu
breast cancer
Ultomiris
Tezspire
AstraZeneca's Ultomiris scores its 3rd FDA approval, setting up market clash with argenx
Fierce Pharma
Thu, 04/28/22 - 11:05 am
AstraZeneca
Ultomiris
FDA
myasthenia gravis
After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl
Fierce Pharma
Thu, 03/17/22 - 10:38 am
AstraZeneca
Roche
Chugai
Ultomiris
patents
Roche and AstraZeneca settle years long patent battle over Ultomiris — report
Endpoints
Sun, 02/20/22 - 11:48 am
Roche
Chugai
AstraZeneca
Alexion
patents
Ultomiris
Soliris
AZ’s Alexion takeover hits a snag, as Ultomiris flunks ALS trial
Pharmaforum
Sun, 08/22/21 - 09:50 pm
AstraZeneca
Ultomiris
ALS
Alexion's new blockbuster Ultomiris keeps gaining steam as $39B AstraZeneca deal looms
Fierce Pharma
Wed, 07/21/21 - 12:01 am
AstraZeneca
Alexion
Ultomiris
Alexion touts new PhIII data of Soliris successor as planned AstraZeneca takeover looms
Endpoints
Fri, 07/16/21 - 10:40 am
Alexion
AstraZeneca
M&A
clinical trials
Ultomiris
myasthenia gravis
Key third-quarter readouts for big pharma
EP Vantage
Tue, 06/29/21 - 10:59 am
clinical trials
Pfizer
Roche
idanacogene elaparvovec
Alexion
AstraZeneca
Ultomiris
AbbVie
Rinvoq
Novartis
sabatolimab
Alexion trials rare disease drug Ultomiris in severe COVID-19 cases
Pharmaforum
Tue, 04/21/20 - 12:28 pm
Alexion
Ultomiris
COVID-19
Alexion to start Phase III study of blood disorder drug in Covid-19 respiratory disease
MedCity News
Mon, 04/20/20 - 10:40 am
Alexion
COVID-19
Ultomiris
clinical trials
Alexion to Start Pivotal Study on Ultomiris for ALS in Q1
Yahoo/Zacks.com
Thu, 01/16/20 - 10:14 am
Alexion
ALS
Ultomiris
clinical trials
Roche's Chugai claims Alexion co-opted its patented tech in building Ultomiris
Fierce Pharma
Wed, 11/13/19 - 11:24 pm
Alexion
Chugai
Roche
Ultomiris
patents
FDA approves Alexion's Ultomiris for another rare blood disease
Yahoo/Reuters
Sun, 10/20/19 - 05:31 pm
Alexion
FDA
Ultomiris
aHUS
Alexion's beating forecasts with Soliris-to-Ultomiris switch. So what's up with its pesky stock price?
Fierce Pharma
Fri, 07/26/19 - 11:05 am
Alexion
Soliris
Ultomiris
PNH
Alexion’s Soliris follow-up Ultomiris snares EU approval
Pharmaforum
Sun, 07/7/19 - 11:13 am
Alexion
Europe
Ultomiris
Soliris
patents
PNH
Pages
1
2
next ›
last »